Abstract:Cell-intrinsic reporters such as luciferase (LUC) and red fluorescent protein (RFP) have been commonly utilized in preclinical studies to image tumor growth and to monitor therapeutic responses. While extrinsic reporters that emit near infrared I (NIR-I: 650-950 nm) or near-infrared II (NIR-II: 1000 -1700 nm) optical signals have enabled minimization of tissue autofluorescence and light scattering, it has remained unclear as to whether their use has afforded more accurate tumor imaging in small animals. Here, we developed a novel optical imaging construct comprised of rare earth lanthanide nanoparticles coated with biodegradable diblock copolymers and doped with organic fluorophores, generating NIR-I and NIR-II emissive bands upon optical excitation. Simultaneous injection of multiple spectrally-unique nanoparticles into mice bearing tumor implants established via intraperitoneal dissemination of LUC+/ RFP+ OVCAR-8 ovarian cancer cells enabled direct comparisons of imaging with extrinsic vs. intrinsic reporters, NIR-II vs. NIR-I signals, as well as targeted vs. untargeted exogenous contrast agents in the same animal and over time. We discovered that in vivo optical imaging at NIR-II wavelengths facilitates more accurate detection of smaller and earlier tumor deposits, offering enhanced sensitivity, improved spatial contrast, and increased depths of tissue penetration as compared to imaging with visible or NIR-I fluorescent agents. Our work further highlights the hitherto underappreciated enhancements in tumor accumulation that may be achieved with intraperitoneal as opposed to intravenous administration of nanoparticles. Lastly, we found discrepancies in the fidelity of tumor uptake that could be obtained by utilizing small molecules for in vivo as opposed to in vitro targeting of nanoparticles to disseminated tumors. (C) 2017 Elsevier Ltd. All rights reserved.

In vivo optical imaging of cancer cell function and tumor microenvironment

Early Tumor Detection Afforded by in Vivo Imaging of Near-Infrared Ii Fluorescence

Intravital Fluorescence Facilitates Measurement of Multiple Physiologic Functions and Gene Expression in Tumors of Live Animals

Optical Molecular Imaging for Tumor Detection and Image-Guided Surgery.

In vivo fluorescence imaging: success in preclinical imaging paves the way for clinical applications

NIR fluorescence imaging and treatment for cancer immunotherapy

In vivo optical imaging of anti-tumor immune response

Harnessing Bioluminescence: A Comprehensive Review of In Vivo Imaging for Disease Monitoring and Therapeutic Intervention

Bioluminescence Imaging of Hollow Fibers in Living Animals: Its Application in Monitoring Molecular Pathways.

Recent Advances in Bioluminescence Tomography: Methodology and System As Well As Application

New optical molecular imaging systems.

The Application of In Vivo Optical Imaging Technologies with Bioluminescence and Fluorescence on the Research of Stem Cell

In Vivo Fluorescence Reflectance Imaging with Subcutaneous Mouse Tumor Models.

Recent Advances in Optical Imaging of Biomarkers in Vivo

Intravital imaging of the functions of immune cells in the tumor microenvironment during immunotherapy

High spatiotemporal resolution and low photo-toxicity fluorescence imaging in live cells and in vivo.

Emerging Synthetic Bioluminescent Reactions for Non-Invasive Imaging of Freely Moving Animals

New in vivo optical molecular imaging modalities

Bioluminescence in-vivo imaging technology and its application in the study of viral infection--a review]

Progress of In Vivo Optical Imaging

Optical Imaging: Bacteria, Viruses, and Mammalian Cells Encoding Light-Emitting Proteins Reveal the Locations of Primary Tumors and Metastases in Animals